Matthew A. Powell, Oleksandr Zub, Nicoline Raashouu-Jensen, Lucy Gilbert, Antoinetta J.M. Beijers, Lyndsay Willmott, Martina Gropp-Meier, Kari Ring, Elisabeth Berge Nilsen, Amy J. Armstrong, Nicole Suzanne Nevadunsky, Sarah Gill, Robert W. Holloway, Eirwen Miller, John Paul Diaz, Michael Teneriello, Katherine Mays, Laura Katherine Austin, Carolyn K. McCourt, Trine Jakobi Noettrup. "Long-term survival rates and cure modeling with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.5501